Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLK1 is a serine/threonine kinase that plays a crucial role in cell cycle progression, particularly during mitosis. It regulates various processes including mitotic entry, spindle assembly, chromosome segregation, and cytokinesis. PLK1 is frequently overexpressed in various cancers, promoting uncontrolled cell proliferation and chromosomal instability, making it a promising target for anticancer drug development.
Inhibition of PLK1 catalytic activity leads to mitotic arrest and apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polo-like kinase family member PLK1 (PLK1).